Hyperhomocysteinemia

Hyperhomocysteinemia has been studied in 3 papers since 2019: 2 observational studies in people, 1 review; 1 in the past year. The newest paper, Jul 30, 2026: “Hyperhomocysteinemia and the risk of silent brain infarcts: systematic review and meta-analysis”.

Exposure

3 papers study it6 findingsUpdated

See all 3 papers on hyperhomocysteinemia

At a glance

The findings reach people, from one lab or study. 3 independent labs in 3 countries.

“HWC/HHcy(+) group having the highest risk (OR = 13.52; 95% CI = 8.61-14.55)”
Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up StudyFrontiers in cardiovascular medicine2022doi:10.3389/fcvm.2021.811670

None of its findings points the other way.

Humans: a single group. Cells, worms or flies and mice: nothing yet.
  • 3 independent labs in 3 countries
  • Funders: National Natural Science Foundation of China and others
  • Humans2

What did studies of hyperhomocysteinemia find?

2

Studies of hyperhomocysteinemia measured 2 outcomes: MMSE and intrinsic capacity Z-score.

MMSE

no changein humans1

1 study
  1. Hyperhomocysteinemia showed no clear effect on MMSE in humans (mean difference -1.55, 95% CI -3.60-0.50).

    “MMSE scores were numerically lower in patients with hyperhomocysteinemia but did not differ significantly from controls (mean difference -1.55; 95% CI -3.60-0.50; P = 0.14).”

    Review

    Hyperhomocysteinemia and the risk of silent brain infarcts: systematic review and meta-analysis

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

More on MMSE

Intrinsic capacity Z-score

downin humans1

1 study
  1. Hyperhomocysteinemia is linked with lower intrinsic capacity Z-score in humans.

    “Participants with HHcy also presented IC Z-score decreases over time.”

    Humans5 yearsn = 1,516

    Associations of C-reactive protein and homocysteine concentrations with the impairment of intrinsic capacity domains over a 5-year follow-up among community-dwelling older adults at risk of cognitive decline (MAPT Study)

    Experimental gerontology

More on Intrinsic capacity Z-score

What is hyperhomocysteinemia linked with?

4

Studies link hyperhomocysteinemia with 4 measures, among them silent brain infarct, mortality and cardiovascular disease mortality.

Silent brain infarct

upin humans1OR 1.84

1 study
  1. Hyperhomocysteinemia raises the risk of silent brain infarct in humans (OR 1.84, 95% CI 1.09-3.11).

    “The rate of silent brain infarcts was 23.4% (253/1087) in patients with hyperhomocysteinemia versus 22.8% (284/1244) in controls (OR 1.84; 95% CI 1.09-3.11; P = 0.02).”

    Reviewbrainn = 2,331

    Hyperhomocysteinemia and the risk of silent brain infarcts: systematic review and meta-analysis

    Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association

More on Silent brain infarct

Mortality

upin humans1HR 1.23

1 study
  1. Hyperhomocysteinemia is linked with a higher risk of mortality in humans with abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-) (HR = 1.23; 95% CI = 1.04-2.18).

    “all-cause mortality (HR = 1.23; 95% CI = 1.04-2.18) of HWC/HHcy(+) group increased considerably after adjustment for major MetS and CVD risk factors”

    Humanswith abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-)7-year follow-upn = 3,675

    Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up Study

    Frontiers in cardiovascular medicine

Cardiovascular disease mortality

upin humans1HR 1.75

1 study
  1. Hyperhomocysteinemia is linked with a higher risk of cardiovascular disease mortality in humans with abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-) (HR = 1.75; 95% CI = 1.02-3.03).

    “risk of 7-year follow-up CVD mortality (HR = 1.75; 95% CI = 1.02-3.03) and all-cause mortality (HR = 1.23; 95% CI = 1.04-2.18) of HWC/HHcy(+) group increased considerably”

    Humanswith abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-)7-year follow-upn = 3,675

    Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up Study

    Frontiers in cardiovascular medicine

Metabolic syndrome

upin humans1OR 13.52

1 study
  1. Hyperhomocysteinemia is linked with a higher risk of metabolic syndrome in humans with abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-) (OR = 13.52; 95% CI = 8.61-14.55).

    “HWC/HHcy(+) group having the highest risk (OR = 13.52; 95% CI = 8.61-14.55)”

    Humanswith abdominal obesity [HWC/HHcy(+)] vs NWC/HHcy(-)7-yearn = 3,675

    Hyperhomocysteinemia Increases Risk of Metabolic Syndrome and Cardiovascular Death in an Elderly Chinese Community Population of a 7-Year Follow-Up Study

    Frontiers in cardiovascular medicine

More on Metabolic syndrome

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months